Orally administrated acetate inhibits atherosclerosis progression through AMPK activation via GPR43 in plaque macrophages

Authors: Wada, Toshiaki ^a, Senokuchi, Takafumi ^{a, ⁎}, Shi, Yudan ^a, Furusho, Tatsuya ^a, Morita, Yutaro ^b, Sarie, Maeda ^a, Hanatani, Satoko ^a, Fukuda, Kazuki ^a, Ishii, Norio ^c, Matsumura, Takeshi ^a, Fujiwara, Yukio ^d, Komohara, Yoshihiro ^d, Araki, Eiichi ^{a, e, f}, Kubota, Naoto ^a

Source: In Atherosclerosis February 2025 401

An ADAM17 selective inhibitor promotes glucose uptake by activating AMPK

Authors: Toma, Tsugumasa, Miyakawa, Nobukazu, Tateishi, Mika, Todaka, Mikio, Kondo, Tatsuya, Fujita, Mikako, Otsuka, Masami, Araki, Eiichi, Tateishi, Hiroshi

Source: In Journal of Pharmacological Sciences January 2024 154(1):37-46

Impact of COVID‐19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study

Authors: Bouchi, Ryotaro, Sugiyama, Takehiro, Goto, Atsushi, Ohsugi, Mitsuru, Yoshioka, Narihito, Katagiri, Hideki, Mita, Tomoya, Hirota, Yushi, Ikegami, Hiroshi, Matsuhisa, Munehide, Araki, Eiichi, Yokoyama, Hiroki, Minami, Masae, Yamazaki, Katsuya, Jinnouchi, Hideaki, Ikeda, Hiroki, Fujii, Hitomi, Nogawa, Miyuki, Kaneshige, Masahiro, Miyo, Kengo, Ueki, Kohjiro

Source: Journal of diabetes investigation. 14(8):994-1004

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187880634.0x000001&indx=1&recIds=ETOCvdc_100187880634.0x000001

Updates of incretin‐related drugs for the treatment of type 2 diabetes

Authors: Araki, Hirotaka, Matsumura, Takeshi, Furukawa, Noboru, Araki, Eiichi

Source: Journal of diabetes investigation. 14(2):189-192

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173074702.0x000001&indx=1&recIds=ETOCvdc_100173074702.0x000001

Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post‐hoc analysis

Authors: Araki, Eiichi, Harashima, Shinichi, Nishida, Tomoyuki, Nakamura, Jiro

Source: Journal of diabetes investigation. 13(12):1971-1980

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185043773.0x000001&indx=1&recIds=ETOCvdc_100185043773.0x000001

Factors Affecting Human Damage in Heavy Rains and Typhoon Disasters

Authors: Naito, Hisaki, Sueta, Daisuke, Hanatani, Satoko, Ikeda, Hatsuo, Hirosue, Akiyuki, Senokuchi, Takafumi, Araki, Eiichi, Tsujita, Kenichi, Nakayama, Hideki, Kasaoka, Shunji

Source: Tohoku journal of experimental medicine. 256(2):175-185

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN630111119&indx=1&recIds=ETOCRN630111119

Age-Related Glucose Intolerance Is Associated with Impaired Insulin Secretion in Community-Dwelling Japanese Adults: The Kumamoto Koshi Study.

Authors: Fukuda, Kazuki, Haneda, Masaki, Kubota, Naoto, Araki, Eiichi, Yamagata, Kazuya

Source: Biomedicines; Feb2025, Vol. 13 Issue 2, p380, 13p

Subject Terms: JAPANESE people, GLUCOSE tolerance tests, INSULIN sensitivity, MULTIPLE regression analysis, GLUCOSE intolerance

A homogeneous assay to determine high-density lipoprotein subclass cholesterol in serum

Authors: Matsushima-Nagata, Kazumi, Sugiuchi, Hiroyuki, Anraku, Kensaku, Takao, Takako, Kondo, Yuki, Ishitsuka, Yoichi, Irikura, Mitsuru, Irie, Tetsumi, Matsumura, Takeshi, Araki, Eiichi, Sumida, Mizuki, Katayama, Yuki, Kayahara, Norihiko

Source: In Analytical Biochemistry 15 January 2021 613

Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials

Authors: Araki, Eiichi, Terauchi, Yasuo, Watada, Hirotaka, Deenadayalan, Srikanth, Christiansen, Erik, Horio, Hiroshi, Kadowaki, Takashi

Source: Diabetes, obesity & metabolism. 23(12):2785-2794

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100133151472.0x000001&indx=1&recIds=ETOCvdc_100133151472.0x000001

Clinical profiles of hyperglycemic crises: A single‐center retrospective study from Japan

Authors: Nishikawa, Takeshi, Kinoshita, Hiroyuki, Ono, Keiko, Kodama‐Hashimoto, Shoko, Kobayashi, Yuka, Nakamura, Tomofumi, Yoshinaga, Tomoaki, Ohkubo, Yuma, Harada, Masahiro, Toyonaga, Tetsushi, Takahashi, Takeshi, Araki, Eiichi

Source: Journal of diabetes investigation. 12(8):1359-1366

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125735730.0x000001&indx=1&recIds=ETOCvdc_100125735730.0x000001

Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT‐2 study

Authors: Araki, Eiichi, Mathieu, Chantal, Shiraiwa, Toshihiko, Maeda, Hajime, Ikeda, Hiroki, Thoren, Fredrik, Arya, Niki, Asano, Michiko, Iqbal, Nayyar

Source: Diabetes, obesity & metabolism. 23(7):1496-1504

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121661821.0x000001&indx=1&recIds=ETOCvdc_100121661821.0x000001

Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT‐1 and ‐2 studies

Authors: Phillip, Moshe, Mathieu, Chantal, Lind, Marcus, Araki, Eiichi, Bartolo, Paolo, Bergenstal, Richard, Heller, Simon, Hansen, Lars, Scheerer, Markus Florian, Thoren, Fredrik, Arya, Niki, Xu, John, Iqbal, Nayyar, Dandona, Paresh

Source: Diabetes, obesity & metabolism. 23(2):549-560

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100119662566.0x000001&indx=1&recIds=ETOCvdc_100119662566.0x000001

Rapid and dramatic glucose‐lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma

Authors: Igata, Motoyuki, Yagi, Yoshitaka, Hanatani, Satoko, Sakaguchi, Masaji, Ishii, Norio, Yoshinaga, Kayo, Kawashima, Junji, Motoshima, Hiroyuki, Araki, Eiichi

Source: Journal of diabetes investigation. 12(4):668-671

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100119313190.0x000001&indx=1&recIds=ETOCvdc_100119313190.0x000001

Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version).

Authors: Nakamura, Jiro, Yoshioka, Narihito, Katagiri, Hideki, Ueki, Kohjiro, Yamauchi, Toshimasa, Inagaki, Nobuya, Tanizawa, Yukio, Araki, Eiichi, Nakayama, Takeo, Kamiya, Hideki

Source: Journal of Diabetes Investigation; Dec2024, Vol. 15 Issue 12, p1821-1837, 17p

Subject Terms: CORONARY disease, MYOCARDIAL ischemia, MYOCARDIAL infarction, GLYCEMIC control, HEART failure patients, CAUSE of death statistics

Hepatic SerpinA1 improves energy and glucose metabolism through regulation of preadipocyte proliferation and UCP1 expression.

Authors: Okagawa, Shota, Sakaguchi, Masaji, Okubo, Yuma, Takekuma, Yuri, Igata, Motoyuki, Kondo, Tatsuya, Takeda, Naoki, Araki, Kimi, Brandao, Bruna Brasil, Qian, Wei-Jun, Tseng, Yu-Hua, Kulkarni, Rohit N., Kubota, Naoto, Kahn, C. Ronald, Araki, Eiichi

Source: Nature Communications; 11/12/2024, Vol. 15 Issue 1, p1-19, 19p

Subject Terms: BROWN adipose tissue, ADIPOSE tissues, EPHRIN receptors, METABOLIC regulation, UNCOUPLING proteins, FAT cells

An antifibrotic compound that ameliorates hyperglycaemia and fat accumulation in cell and HFD mouse models.

Authors: Toma, Tsugumasa, Miyakawa, Nobukazu, Arakaki, Yuiichi, Watanabe, Takuro, Nakahara, Ryosei, Ali, Taha F. S., Biswas, Tanima, Todaka, Mikio, Kondo, Tatsuya, Fujita, Mikako, Otsuka, Masami, Araki, Eiichi, Tateishi, Hiroshi

Source: Diabetologia; Nov2024, Vol. 67 Issue 11, p2568-2584, 17p

Causes of death in Japanese patients with diabetes based on the results of survey of 68,555 cases during 2011–2020: committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version).

Authors: Nakamura, Jiro, Yoshioka, Narihito, Katagiri, Hideki, Ueki, Kohjiro, Yamauchi, Toshimasa, Inagaki, Nobuya, Tanizawa, Yukio, Araki, Eiichi, Nakayama, Takeo, Kamiya, Hideki

Source: Diabetology International; Oct2024, Vol. 15 Issue 4, p641-665, 25p

Potential of a glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes

Authors: Araki, Eiichi, Sakaguchi, Masaji, Fukuda, Kazuki, Kondo, Tatsuya

Source: Journal of diabetes investigation. 13(12):1958-1960

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185968961.0x000001&indx=1&recIds=ETOCvdc_100185968961.0x000001

Pioglitazone suppresses macrophage proliferation in apolipoprotein-E deficient mice by activating PPARγ

Authors: Murakami-Nishida, Saiko, Matsumura, Takeshi, Senokuchi, Takafumi, Ishii, Norio, Kinoshita, Hiroyuki, Yamada, Sarie, Morita, Yutaro, Nishida, Shuhei, Motoshima, Hiroyuki, Kondo, Tatsuya, Komohara, Yoshihiro, Araki, Eiichi

Source: In Atherosclerosis July 2019 286:30-39

Brown adipocyte-derived exosomal miR-132-3p suppress hepatic Srebf1 expression and thereby attenuate expression of lipogenic genes

Authors: Kariba, Yuichi, Yoshizawa, Tatsuya, Sato, Yoshifumi, Tsuyama, Tomonori, Araki, Eiichi, Yamagata, Kazuya

Source: Biochemical and biophysical research communications. 530(3):500-507

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100128435407.0x000001&indx=1&recIds=ETOCvdc_100128435407.0x000001